Evidence map›Paper›PMID 35606424›Full record

ArticleNature microbiology2022

Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile.

Mónica L Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, Fabio Paredes, Claudia P Cortes, Sergio Pantano, Constanza Martínez-Valdebenito and 6 more

Abstract readPublished Erratum
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Mónica L Acevedo *Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Aracelly Gaete-Argel *Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Luis Alonso-PalomaresLaboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Marco Montes de OcaEscuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.
Andrés BustamanteLaboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Aldo GaggeroLaboratorio de Virología Ambiental, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Fabio ParedesDepartamento de Epidemiología, Ministerio de Salud de Chile, Santiago, Chile.
Claudia P CortesClínica Santa María, Santiago, Chile.ORCID http://orcid.org/0000-0001-9101-9783
Sergio PantanoBiomolecular Simulations Group, Instituto Pasteur de Montevideo, Montevideo, Uruguay.ORCID http://orcid.org/0000-0001-6435-4543
Constanza Martínez-ValdebenitoDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-2836-9817
Jenniffer AnguloDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Nicole Le CorreDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Marcela FerrésDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Marcelo A NavarreteEscuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.ORCID http://orcid.org/0000-0002-2044-9548
Fernando Valiente-EcheverríaLaboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile. fvaliente@uchile.cl.ORCID http://orcid.org/0000-0001-9156-2516
Ricardo Soto-RifoLaboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile. rsotorifo@uchile.cl.ORCID http://orcid.org/0000-0003-0945-2970

Funding

Consejo Nacional de Ciencia y Tecnología (National Council of Science and Technology, Mexico) SECTEI/138/2019Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 1180882Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 1181656Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 1190156Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 1211547Fondo Nacional de Desarrollo Científico y Tecnológico (National Fund for Scientific and Technological Development) 3200460
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35606424
PMCPMC9125951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.